Merge adds MRI CAD with $22M Confirma acquisition

Justine Varieur Cadet | | Health Exec | Precision Medicine
Health IT developer Merge Healthcare has entered a definitive agreement to acquire MRI computer-aided detection (CAD) application developer Confirma in an all-stock transaction.

The acquisition will bring an MRI CAD product to the portfolio of the Milwaukee-based Merge.

"CAD technology is still at an early adoption phase in the market for most indications, but it has significant opportunity as a tool for reducing imaging costs," said Justin Dearborn, Merge's CEO.

The total value of the all-stock transaction is estimated to be $22 million, using a ten-day volume weighted average of Merge's common stock price as of the close of market on Aug. 6. Based on the amount of stock offered, it is estimated that investors in the Seattle-based Confirma will own approximately 8.5 percent of Merge, post-acquisition.

Confirma has developed CAD algorithms, intellectual property and validation required of the clinical tools, the companies said. Its CADstream product has more than 1,200 systems implemented for breast and prostate MRI. 

Merge expects the transaction to be completed this September.

Justine Varieur Cadet

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Design by Adaptive Theme
Trimed Popup
Trimed Popup